HA
AMGN icon

Huntleigh Advisors’s Amgen AMGN Stock Holding History

Huntleigh Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.09M Buy
11,626
+954
+9% +$340K 0.7% 35
2025
Q4 		$3.49M Buy
10,672
+787
+8% +$250K 0.59% 39
2025
Q3 		$2.79M Sell
9,885
-25
-0.3% -$7.25K 0.48% 53
2025
Q2 		$2.77M Buy
9,910
+368
+4% +$104K 0.53% 45
2025
Q1 		$2.97M Buy
9,542
+184
+2% +$54.3K 0.7% 38
2024
Q4 		$2.44M Buy
+9,358
New +$2.78M 0.53% 46

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Huntleigh Advisors's AMGN Position: Q1 2026 in Review

Huntleigh Advisors increased its Amgen (AMGN) stake by 8.9% in Q1 2026, buying an estimated $340K and bringing the position to 11,626 shares worth $4.09M. The position accounts for 0.7% of the portfolio, ranked #35.

Huntleigh Advisors first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Huntleigh Advisors held 11,626 shares of Amgen worth $4.09M as of Q1 2026.
  • Huntleigh Advisors bought 954 Amgen shares in Q1 2026, an estimated $340K.
  • Amgen made up 0.7% of Huntleigh Advisors's portfolio in Q1 2026, its #35 holding.
  • Huntleigh Advisors first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Huntleigh Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.